Vivos Therapeutics, Inc. (VVOS)
USD 2.57
(0.0%)
USD 2.57
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 24.94 Million USD | -28.83% |
| 2022 | 35.05 Million USD | 9.28% |
| 2021 | 32.07 Million USD | 67.74% |
| 2020 | 19.12 Million USD | -0.59% |
| 2019 | 19.23 Million USD | 74.12% |
| 2018 | 11.04 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 5.57 Million USD | -8.18% |
| 2024 Q2 | 4.44 Million USD | -20.34% |
| 2023 Q2 | 6.61 Million USD | -9.9% |
| 2023 Q1 | 7.34 Million USD | -13.08% |
| 2023 FY | 24.94 Million USD | -28.83% |
| 2023 Q4 | 6.07 Million USD | 12.73% |
| 2023 Q3 | 5.38 Million USD | -18.56% |
| 2022 Q3 | 7.9 Million USD | -17.26% |
| 2022 Q2 | 9.55 Million USD | 3.94% |
| 2022 Q1 | 9.19 Million USD | -4.35% |
| 2022 FY | 35.05 Million USD | 9.28% |
| 2022 Q4 | 8.44 Million USD | 6.88% |
| 2021 Q1 | 6.09 Million USD | 8.78% |
| 2021 FY | 32.07 Million USD | 67.74% |
| 2021 Q2 | 7.68 Million USD | 26.06% |
| 2021 Q3 | 8.68 Million USD | 13.01% |
| 2021 Q4 | 9.6 Million USD | 10.62% |
| 2020 Q2 | 4.14 Million USD | -16.69% |
| 2020 FY | 19.12 Million USD | -0.59% |
| 2020 Q4 | 5.6 Million USD | 27.39% |
| 2020 Q3 | 4.39 Million USD | 6.18% |
| 2020 Q1 | 4.97 Million USD | 5.4% |
| 2019 Q2 | 4.44 Million USD | -0.0% |
| 2019 Q4 | 4.71 Million USD | -16.04% |
| 2019 Q3 | 5.62 Million USD | 26.37% |
| 2019 Q1 | 4.44 Million USD | 0.0% |
| 2019 FY | 19.23 Million USD | 74.12% |
| 2018 FY | 11.04 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -122.256% |
| Cerus Corporation | 143.15 Million USD | 82.574% |
| OrthoPediatrics Corp. | 137.01 Million USD | 81.794% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -119.578% |
| Talis Biomedical Corporation | 67.18 Million USD | 62.87% |
| Inogen, Inc. | 236.08 Million USD | 89.433% |
| Spectral AI, Inc. | 20.86 Million USD | -19.565% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 55.451% |
| CVRx, Inc. | 76.14 Million USD | 67.238% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -607.087% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -99.744% |
| Orthofix Medical Inc. | 667.42 Million USD | 96.262% |
| Venus Concept Inc. | 80.47 Million USD | 69.002% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 55.909% |
| Bioventus Inc. | 409.91 Million USD | 93.914% |
| BrainsWay Ltd. | 28.01 Million USD | 10.964% |
| Envoy Medical, Inc. | 17.89 Million USD | -39.379% |
| electroCore, Inc. | 32.03 Million USD | 22.119% |
| IceCure Medical Ltd | 16.87 Million USD | -47.819% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 41.209% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -41.473% |
| MaxCyte, Inc. | 84.84 Million USD | 70.598% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -100.987% |
| Nexalin Technology, Inc. | 5.78 Million USD | -331.49% |
| PAVmed Inc | 64.82 Million USD | 61.519% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 51.161% |
| RxSight, Inc. | 103.85 Million USD | 75.979% |
| Sight Sciences, Inc. | 126.44 Million USD | 80.272% |
| SI-BONE, Inc. | 156.35 Million USD | 84.045% |
| TELA Bio, Inc. | 84.18 Million USD | 70.368% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 64.391% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 87.733% |
| LivaNova PLC | 843.54 Million USD | 97.043% |
| 908 Devices Inc. | 68.08 Million USD | 63.358% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 94.842% |
| Nemaura Medical Inc. | 7.13 Million USD | -249.442% |
| NeuroPace, Inc. | 75.29 Million USD | 66.869% |
| LENSAR, Inc. | 33.33 Million USD | 25.168% |
| Apyx Medical Corporation | 51.01 Million USD | 51.104% |
| Cutera, Inc. | 197.72 Million USD | 87.383% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -0.666% |
| BioSig Technologies, Inc. | 28.53 Million USD | 12.562% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 86.972% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 30.821% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 97.017% |
| Axonics, Inc. | 270.2 Million USD | 90.768% |
| Outset Medical, Inc. | 198.77 Million USD | 87.45% |
| IRIDEX Corporation | 31.81 Million USD | 21.588% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 86.158% |
| IRadimed Corporation | 30.12 Million USD | 17.186% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -192.382% |
| INVO Bioscience, Inc. | 7.85 Million USD | -217.65% |
| Telesis Bio, Inc. | 63.48 Million USD | 60.708% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 74.662% |
| Varex Imaging Corporation | 224.8 Million USD | 88.903% |
| Quipt Home Medical Corp. | 148.66 Million USD | 83.22% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -112.795% |
| Pulmonx Corporation | 112.68 Million USD | 77.863% |
| Dynatronics Corporation | 9.9 Million USD | -151.776% |
| Modular Medical, Inc. | 17.52 Million USD | -42.313% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -23.575% |
| Semler Scientific, Inc. | 38.94 Million USD | 35.944% |
| InMode Ltd. | 215.68 Million USD | 88.434% |
| Bruker Corporation | 1.07 Billion USD | 97.682% |
| Cytosorbents Corporation | 48.33 Million USD | 48.391% |
| DexCom, Inc. | 1.69 Billion USD | 98.525% |
| Align Technology, Inc. | 2.07 Billion USD | 98.799% |
| Viveve Medical, Inc. | 22.17 Million USD | -12.506% |
| ZimVie Inc. | 275.12 Million USD | 90.933% |
| Movano Inc. | 29.69 Million USD | 15.978% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 81.827% |
| Nexalin Technology, Inc. | 5.78 Million USD | -331.49% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -607.087% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 95.849% |
| Profound Medical Corp. | 33.6 Million USD | 25.763% |
| Insulet Corporation | 939.9 Million USD | 97.346% |
| enVVeno Medical Corporation | 25.23 Million USD | 1.157% |
| Surmodics, Inc. | 98.69 Million USD | 74.725% |
| iCAD, Inc. | 22.22 Million USD | -12.243% |
| Nuwellis, Inc. | 22.61 Million USD | -10.317% |
| Biotricity, Inc. | 17.18 Million USD | -45.165% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 94.405% |
| Aethlon Medical, Inc. | 12.27 Million USD | -103.185% |
| InspireMD, Inc. | 22.95 Million USD | -8.697% |
| PAVmed Inc. | 64.82 Million USD | 61.519% |
| BIOLASE, Inc. | 34.66 Million USD | 28.029% |
| Beyond Air, Inc. | 61.7 Million USD | 59.569% |
| FONAR Corporation | 28.6 Million USD | 12.79% |
| AxoGen, Inc. | 149.33 Million USD | 83.295% |
| Vivani Medical, Inc. | 26.96 Million USD | 7.487% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 85.914% |
| Inari Medical, Inc. | 448.59 Million USD | 94.439% |
| UFP Technologies, Inc. | 58.08 Million USD | 57.056% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -406.251% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -294.822% |
| Tenon Medical, Inc. | 16.96 Million USD | -47.018% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -237.427% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 43.437% |
| AdaptHealth Corp. | 1.07 Billion USD | 97.686% |
| Sintx Technologies, Inc. | 15.2 Million USD | -64.108% |
| NanoVibronix, Inc. | 4.97 Million USD | -401.629% |
| Quanterix Corporation | 118.1 Million USD | 78.877% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -112.795% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -72.732% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 93.647% |
| TransMedics Group, Inc. | 182.82 Million USD | 86.355% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 11.113% |
| NeuroMetrix, Inc. | 11.09 Million USD | -124.76% |
| Hyperfine, Inc. | 52.87 Million USD | 52.818% |
| Establishment Labs Holdings Inc. | 172 Million USD | 85.497% |
| Biomerica, Inc. | 6.97 Million USD | -257.495% |
| Bone Biologics Corporation | 9.42 Million USD | -164.586% |
| AVITA Medical, Inc. | 80.77 Million USD | 69.118% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -141.931% |
| Silk Road Medical, Inc | 186.35 Million USD | 86.614% |